Aging Population Fuels Demand for Osteoarthritis Injections
- - April 14th 2014
Osteoarthritis is an inevitable consequence of aging for most people. In fact, researchers estimate that half of your patients will develop osteoarthritis of the knee by the time they reach the age of 85. Currently, over 50 million people in the U.S. alone have been diagnosed with arthritis, making arthritis treatments a significant and important part of healthcare. However, the number of arthritis patients is expected to increase in coming years. By the year 2030, experts estimate that over 67 million Americans will be diagnosed with arthritis, and this number could grow even more beyond that date.
So what is fueling this increase in osteoarthritis diagnosis? One factor is the aging population. Although osteoarthritis is not limited to older patients, many people do develop osteoarthritis as they age. The "baby boomer" population is the largest demographic group in North America, and this population is reaching and passing retirement age. As this large group ages, there will be an increase in age-related diseases such as osteoarthritis along with Alzheimer's disease and other illnesses. Another factor that is driving up osteoarthritis numbers recently is an increase in obesity and lack of physical activity in North America. Obese patients are supporting extra weight with their knees and often develop osteoarthritis and other joint issues because of the constant pressure on their knees. Adding to the problem is the lack of physical activity to keep joints from getting stiff and, on the flipside, active retirees that may play sports and put extra strain on their joints. The large demographic of aging North Americans, the obesity problem, lack of exercise and active leisure activities are all combining to drive up osteoarthritis numbers now and into the foreseeable future.
What does this mean for you and your medical practice? With an increase in aging and obese patients, spending on healthcare will increase. There will simply be more people needing more services as they get older. As a physician, this means an increase in business for you. More osteoarthritis patients coming into your practice means more people who will need treatments such as SYNVISC® injections. By offering SYNVISC® injections in your practice, you are helping a growing demographic of patients find the relief they need to get on with their active lives.
SYNVISC® is one of a handful of injectable osteoarthritis treatments. You inject SYNVISC® into your patient's knee or other joint, and the hyaluronic acid formula replaces the synovial fluid in the knee. This helps to both lubricate and cushion your patient's knee, so that their bones no longer rub together painfully. Your patients effectively walk on a cushion of fluid so that their inflammation and pain are reduced. Soon they could be back to their normal physical activities instead of being cooped up in their house in pain.
SYNVISC® can help osteoarthritis patients who want to replace or supplement another type of treatment. Your patients have other options like medication and surgery, but medication can have interactions or unpleasant side effects, and surgery can be both painful and costly. SYNVISC® gives your patients an alternative osteoarthritis treatment that is relatively quick and easy.
With more demand expected in the future for age-related medical products and services, now is the time to add SYNVISC® treatments to your medical practice. The number of patients coming to you for osteoarthritis treatment will only grow from here, so make sure you have plenty of SYNVISC® in stock.
You can buy SYNVISC® from Medica Depot HERE.